Xizang Haisco Pharmaceutical Group CO.,LTD



Quote for Xizang Haisco Pharmaceutical Group CO.,LTD

Last Trade:
-
Change:
--
Symbol/Code:
002653
Status:
-
Stock Type:
A Share
Market Cap:
-
Open:
-
Prev Close:
-
Bid:
-
Ask:
-
Volume(*100):
-
Amount:
-
Limit Up:
-
Limit Down:
-
Day's Range:
-
P/E(ttm):
-
P/B ratio
-
Update:-
Currency in CNY Time=UTC+8002653 quote

Summary for Xizang Haisco Pharmaceutical Group CO.,LTD

Xizang Haisco Pharmaceutical Group Co., Ltd. is principally engaged in the research, development, production and sale of chemical drug preparations and bulk drugs. The Company's major products include polyene phosphatidylcholine injections for liver and gall disease treatment, fusidic acid sodium for resist infection, invert sugar injection series for parenteralnutrition, as well as lipid solubility vitamins injections, among others. The Company's polyene phosphatidylcholine injection products are mainly used for the treatment of hepatitis, cirrhosis, fatty liver and bile block. Its lipid solubility vitamins injection products are mainly used to satisfy the needs of lipid solubility vitamin A, vitamin D2, vitamin E and vitamin K1. The Company distributes its products mainly in domestic markets.

Profile for Xizang Haisco Pharmaceutical Group CO.,LTD

Full Name:Xizang Haisco Pharmaceutical Group CO.,LTD
Full Name in Chinese:西藏海思科药业集团股份有限公司 Short Name in Chinese:海思科
Symbol/Stock Code:
002653
Listed in:
Shenzhen Stock Exchange
Issued Capital
-
Negotiable Capital:
-
Chairman:
Wang Junmin
Secretary of the Board:
Deng Xiang
Phone:
+86-893-7834865
Fax:
+86-893-7834866
Official Website:www.haisco.com/
E-mail:haisco@haisco.com
Address:No. 136,,No. 8, Xiangqu East Road, Zedang,SHANNAN SIC 856000
IPO Subscription Date:
2012-01-09
Listing Date:
2012-01-17
IPO Issued Capital:
40100000
IPO Price:
20 CNY
IPO fees:
64956000 CNY
Money Raised by IPO:
802000000 CNY
IPO Par Value:
1.00 CNY
Net Money Raised:
737044000 CNY
Open(Listing day):
17.50 CNY
Close(Listing day):
19.02 CNY
Diluted P/E ratio after IPO:
32.8700
Turnover rate(listing day):
29.62%

Financials for Xizang Haisco Pharmaceutical Group CO.,LTD

UPDATE:2012-10-26 Annual Report Abstract:(All Currency In CNY)

Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Net Profit(after tax)(Million)
296.3867
312.2961
305.753
283.7193
Net Profit Growth(%)
47.22
2.14
7.76
45.43
Return On Equity(ROE)(%)
18.99
40.68
67.48
209.89
Debt ratio(%)
10.57
13.02
28.06
61.31
Net Operating Cash Flow/Net Profit(%)
103.33
83.51
120.16
129.78

Per Share Financial Data:(All Currency In CNY)

Per Share Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Earnings Per Share(EPS)
0.7500
0.8700
0.8700
0.8400
Diluted Earnings Per Share
0.0000
0.6700
0.6900
0.7000
Net Asset Value Per Share (NAVPS)
3.9000
2.1300
1.2600
27.0300
Additional Paid-In Capital Per Share
1.7731
0.0346
0.0280
2.0181
Retained Earnings Per Share
0.9979
0.9526
0.1725
23.4194
Net Cash Flow From Operatings Activities Per Share
0.7700
0.7200
1.0200
1.1000
Net Cash Flow Per Share
1.8361
0.3423
0.7087
8.8418

Balance Sheet:(All Currency In CNY)

Assets And Liabilities/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Total Assets(Million)
1745.7038
882.705
629.8832
349.393
Total Liabilities(Million)
184.5764
114.9482
176.7926
214.2193
Current Liabilities(Million)
147.7404
77.7798
123.6422
211.3673
Long Term Liabilities(Million)
-
-
-
-
Cash And Cash Equivalents(Million)
1233.0225
498.4166
375.5416
120.7245
Accounts Receivables(Million)
6.1884
2.1552
-
2.5424
Deposit Received(Million)
20.9899
22.2342
17.621
33.5482
Other Receivables(Million)
19.0691
14.6159
14.8978
49.6449
Bad Debt Reserve(Million)
-
-
-
-
Shareholder's Equity/Owner's Equity(Million)
1561.1274
767.7568
453.0906
135.1737
Debt ratio(%)
10.57
13.02
28.06
61.31
Equity Ratio(%)
89.4200
86.9700
71.9300
38.6800
Current Ratio
9.4157
7.6337
3.4887
1.0747
Quick Ratio
9.2263
7.2735
3.3215
0.8893

Cash Flow Statement:(All Currency In CNY)

Cash Flow/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Cash From Selling Commodities(Million)
689.1709
708.7855
707.312
629.741
Net Cash Flow From Operatings Activities(Million)
306.2452
260.794
367.381
368.2136
Net Cash Flow From Operatings Activities Change(%)
123.65
-29.01
-0.23
289.87
Net Cash Flow(Million)
734.6059
123.2361
255.1174
44.209
Cash From Selling Commodities/Prime Revenue(%)
129.28
117.27
121.62
129.96
Net Cash Flow/Net Profit(%)
247.85
39.46
83.44
15.58
Cash Flow From Investing Activities(Million)
-116.9247
-117.6371
-80.414
-41.0707
Cash Flow From Financing Activities(Million)
545.2854
-19.9208
-31.8497
-282.9339

Income Statement:(All Currency In CNY)

Income Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Prime Operating Revenue(Million)
533.0698
604.4297
581.5851
484.5712
Prime Operating Profit(Million)
-
-
-
-
Operating Costs(Million)
73.0303
26.6812
20.4896
19.231
Administrative Costs(Million)
98.0421
87.3312
65.0759
52.7629
Financing Costs(Million)
-20.1624
-6.4583
0.2477
1.3191
Above Three Costs Change(%)
88.63
25.34
17.05
101.25
Operating Profit(Million)
232.2459
287.3618
290.6907
269.3592
Income From Investment(Million)
1.5419
-
-
-0.0087
Government Subsidies(Million)
-
-
-
-
Net Non-Operating Income And Expense(Million)
93.6751
82.0261
73.1783
46.2428
Total Profit(Million)
325.921
369.3879
363.869
315.6019
Corporate Income Tax(Million)
29.5343
57.0918
58.1161
31.8826
Net Profit(Million)
296.3867
312.2961
305.753
283.7193
Gross Profit Ratio(%)
72.81
66.75
65.66
70.92
Operating Margin(%)
43.56
47.54
49.98
55.58
Return On Equity(ROE)(%)
18.99
40.68
67.48
209.89

Announcements for Xizang Haisco Pharmaceutical Group CO.,LTD

Date: 2012-10-26
Title: EGM-SPOT
The Company will hold the 1st Extraordinary General Meeting of 2012 at 14:00 on 12 November 2012.

Meeting agenda:
1. To provide entrusted loan to a company


Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 07 November 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.

Registration period: from 07 November 2012 to 07 November 2012
Date: 2012-04-13
Title: PLACING SHARE LISTING
The Company's 8 million A-shares placed to the institutional investors through offline placement will reach the 3-month lock-up period and be listed on the Shenzhen Stock Exchange as of 17 April 2012.
Date: 2012-03-02
Title: DIVIDEND IMPLEMENTATION (CASH ONLY)
2011 final distribution plan to be implemented (A shares):

1. Cash dividend/10 shares (tax included): CNY6.00000000
2. Bonus issue from profit (share/10 shares): none
3. Bonus issue from capital reserve (share/10 shares): none


Record date: 07 March 2012
Ex-date: 08 March 2012
Payment date: 08 March 2012

10 percent withholding tax on cash dividend will be deducted in CNY within the cash dividend receivable. Please refer to below details:
Tax on cash dividend/10 shares: CNY0.60000000(10 percent x CNY6.00000000)
Net cash dividend/10 shares after tax: CNY5.40000000(CNY6.00000000- CNY0.60000000)
Date: 2012-03-01
Title: AGM RESOLUTION
The Company held its Annual General Meeting of 2011 on 29 February 2012, during which the following proposal(s) was/were approved:
1. 2011 work report of the board of directors
2. 2011 work report of the supervisory committee
3. 2011 financial resolution report
4. 2011 annual report and its summary
5. 2011 profit distribution
6. Reappointment of 2012 audit firm
7. Management system for prevention of fund occupation by large shareholders and related parties
The detailed profit distribution plan are as follows:
1) Cash dividend/10 shares (tax included): CNY6.00000000
2) Bonus issue from profit (share/10 shares): none
3) Bonus issue from capital reserve (share/10 shares): none.
Date: 2012-02-09
Title: AGM-SPOT
The Company will hold the 2011 Annual General Meeting at 14:00 on 29 February 2012.

Meeting agenda:
1. 2011 work report of the board of directors
2. 2011 work report of the supervisory committee
3. 2011 financial resolution report
4. 2011 annual report and its summary
5. 2011 profit distribution
6. Reappointment of 2012 audit firm
7. Management system for prevention of fund occupation by large shareholders and related parties
The detailed profit distribution plan are as follows:
1) Cash dividend/10 shares (tax included): CNY6.00000000
2) Bonus issue from profit (share/10 shares): none
3) Bonus issue from capital reserve (share/10 shares): none

Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 23 February 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.

Registration period: 24 February 2012
Date: 2012-02-07
Title: FINAL DIVIDEND
The Company issued its 2011 annual report on 07 February 2012.

The profit distribution proposal for 2011:
1. Cash dividend/10 shares (tax included): CNY6.00000000
2. Bonus issue from profit (share/10 shares):none
3. Bonus issue from capital reserve (share/10 shares):none.
Date: 2012-01-16
Title: IPO SHARE LISTING
The Company issued a total of 40.1 million shares (code:002653) in its initial public offering. Of the shares,32.1 million shares will be listed on the Shenzhen Stock Exchange on 17 January 2012 while the remainder will become tradable three months later.
Date: 2012-01-06
Title: IPO-ONLINE SUBSCRIPTION
Xizang Haisco Pharmaceutical Group Co., Ltd. has been approved by the China Securities Regulatory Commission (the CSRC) to issue 40.100000 million A-shares in its initial public offering.
1. Class: A shares
2. Stock code: 002653
3. Stock abbreviation: Haisco
4. Issuing volume: 40.100000 million shares
5. Par value: CNY1.00 per share
6. Issuing mechanism: a book building process will be conducted with a combination of online public offering and offline placement.
7. Targeted listing bourse: Shenzhen Stock Exchange
8. Offline placement volume: 8.000000 million shares
9. Online offering volume: 32.100000 million shares
10. Price: CNY20.00 per share
11. Offline subscription period: 09 January 2012
12. Online subscription date: 09 January 2012.
Date: 2011-12-27
Title: IPO
Xizang Haisco Pharmaceutical Group Co., Ltd. has been approved by the China Securities Regulatory Commission (the CSCR) to issue 40.1000 million A-shares in its initial public offering, which is structured as follows:
1.Class: A shares
2.Size: 40.1000 million shares
3.Par value: CNY1.00 per share
4.Issuing mechanism: a book building process will be conducted with a combination of online public offering and offline placement.
5.Targeted listing bourse: Shenzhen Stock Exchange
6.Offline placement volume: 8.0000 million shares
7.Online offering volume:32.1000 million shares
8.IPO price inquiry period: from 28 December 2011 to 04 January 2012
9.IPO price determined: 06 January 2012
10.Offline subscription date:09 January 2012
11.Online subscription date: 09 January 2012
12.Expected listing date:N/A.